Preparation method of diglyceride with uric acid reducing effect

The preparation of diglycerides by a compound enzyme-catalyzed hydrolysis method solves the problem of insufficient diglyceride content, achieves a highly efficient uric acid-lowering effect, and the process is simple and environmentally friendly.

CN121992044APending Publication Date: 2026-05-08PUYANG YIJIAKANG HEALTH TECHNOLOGY CO LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202610366644.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-03-24
Publication Date
2026-05-08

AI Technical Summary

Technical Problem

Existing methods for preparing diglycerides result in insufficient diglyceride content, and the bio-enzymatic preparation process is complex, making it difficult to meet the demand for efficient uric acid reduction.

Method used

A composite enzyme-catalyzed hydrolysis method, including a combination of lipase and keratinase, is used to control the content of free fatty acids. The preparation process involves hydrolysis and esterification in sequence, without the use of organic solvents, and the process steps are optimized to increase the content of diglycerides.

Benefits of technology

The prepared product has a diglyceride content of over 80%, which significantly reduces uric acid, xanthine oxidase activity, and creatinine levels in the serum of hyperuricemic mice, demonstrating excellent uric acid-lowering effects. Moreover, the process is environmentally friendly and pollution-free.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN121992044A_ABST
    Figure CN121992044A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of diglyceride preparation, in particular to a preparation method of diglyceride with a uric acid reducing effect. Comprising the following steps: (1) vegetable oil is partially hydrolyzed with a complex enzyme composed of lipase and cutinase, a hydrolysate is obtained after dehydration, and the content of free fatty acid in the hydrolysate is 37.0 wt%-46.0 wt%; and (2) adding glycerol and lipase into the hydrolysate obtained in the step (1) to react, adding water to remove excessive glycerol, standing for layering, collecting supernatant, and carrying out distillation separation to obtain the edible diglyceride. The content of diglyceride in the final product reaches 80% or above by strictly controlling enzyme composition and free fatty acid in the hydrolysis and esterification processes, the reaction process is carried out according to the hydrolysis and esterification sequence, the process steps are simple, no organic solvent is used in the whole reaction process, green and environment-friendly effects are achieved, and the obtained diglyceride has a remarkable uric acid reducing effect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of diglyceride preparation technology, specifically relating to a method for preparing diglycerides with uric acid-lowering effects. Background Technology

[0002] Diacylglycerol, also known as diglyceride, diacylglycerol, or DAG, is a multifunctional additive. In 1988, Yasukawa and his research group developed a special edible oil that could aid weight loss; the main component of this oil was DAG. Since 1997, Kao Corporation of Japan has continuously developed diglycerides, applying for multiple patents related to diglyceride preparation methods and components in Japan, the United States, and China. Additionally, Cheil Industries of South Korea launched a diglyceride product with weight-loss effects in 2006. In July 2021, diglyceride oil was included in the National Health Commission's list of new food ingredients subject to termination of review, classifying it as a new food ingredient. In June 2021, the Chinese Geriatrics Society formulated the group standard T / GGSS020-2021, "Diglyceride Oil, a Vegetable Oil Suitable for the Elderly," for edible vegetable oils suitable for the elderly. Currently, the preparation methods of diglycerides are mainly divided into chemical methods and bio-enzymatic methods. Compared with chemical methods, bio-enzymatic methods have milder reaction conditions, lower energy consumption, no pollution, and fewer side reactions. Therefore, the preparation of diglycerides by bio-enzymes is a green and environmentally friendly synthesis process. Existing technology Chinese invention patent application CN105400837A discloses an enzyme-catalyzed preparation method of diglycerides, including the following steps: (1) Partial hydrolysis of oil: Edible oil is partially hydrolyzed by enzyme catalysis, and after dehydration, hydrolysate is obtained, such that the content of diglycerides in the hydrolysate is between 30.0wt% and 35.0wt%, and the content of free fatty acids is between 26.0wt% and 30.0wt%; (2) Re-esterification: Glycerol with a mass of 2.5 to 4 times is added to the hydrolysate obtained in step (1), and esterification reaction is carried out by enzyme catalysis to synthesize diglycerides. After removing excess glycerol, the edible diglycerides are obtained. Chinese invention patent application CN119932125A discloses a method for preparing uric acid-lowering diglycerides by enzymatic hydrolysis, its products, and applications. The method includes the following steps: (1) mixing vegetable oil, glycerol, water, and an enzyme preparation to obtain a reaction solution; (2) allowing the reaction solution to stand and separate into layers, and collecting the upper layer; (3) distilling, separating, decolorizing, and deodorizing the upper layer to obtain diglycerides. The enzyme preparation mentioned in step (1) is lipase, esterase, and phospholipase C in a weight ratio of 5-10:0.1-0.3:1. However, the content of diglycerides in the product of the above patent application needs to be further improved.

[0003] Therefore, there is an urgent need to develop a method for preparing diglycerides with uric acid-lowering effects that has simple preparation steps, high diglyceride content in the product. Summary of the Invention

[0004] In view of the prior art, the present invention provides a method for preparing diglycerides with uric acid-lowering effects. By strictly controlling the enzyme composition and free fatty acids during hydrolysis and esterification, the content of diglycerides in the final product reaches more than 80%. Moreover, the reaction process is carried out in the order of hydrolysis and esterification, the process steps are simple, and no organic solvents are used in the entire reaction process, thus achieving green and environmentally friendly results.

[0005] This invention is achieved through the following technical solutions:

[0006] The first aspect of the present invention relates to a method for preparing diglycerides with uric acid-lowering effects, the method comprising the following steps: (1) The vegetable oil is partially hydrolyzed by a complex enzyme catalytic hydrolysis method composed of lipase and keratinase, and the hydrolysate is obtained after dehydration. The free fatty acid content in the hydrolysate is between 37.0 wt% and 46.0 wt%. (2) After adding glycerol and lipase to the hydrolysate obtained in step (1), water is added to remove excess glycerol, the mixture is allowed to stand and separate into layers, the upper layer is collected, and the mixture is separated by distillation to obtain the edible diglyceride.

[0007] Preferably, the mass ratio of keratinase and lipase in the complex enzyme in step (1) is 1:2-5.

[0008] Preferably, the amount of the compound enzyme added in step (1) is 0.5%-1.2% of the mass of the edible oil.

[0009] Preferably, the oil-to-water ratio in the hydrolysis of step (1) is 2-3:1 g / mL.

[0010] Preferably, the reaction temperature in step (1) is 20-40℃ and the reaction time is 2-5h.

[0011] Preferably, the vegetable oil in step (1) is at least one of the following: Acer truncatum seed oil, Hippophae rhamnoides seed oil, low erucic acid rapeseed oil, peony seed oil, corn oil, peanut oil, flaxseed oil, safflower seed oil, and milk thistle seed oil.

[0012] Preferably, the amount of glycerol added in step (2) is 2-3 times the mass of the hydrolysis product in step (1).

[0013] Preferably, the amount of lipase added in step (2) is 0.1%-0.5% of the mass of the hydrolysis product in step (1).

[0014] Preferably, the enzymes described in steps (1) and (2) are immobilized enzymes, which are recovered after the catalytic reaction is completed.

[0015] More preferably, the immobilized enzyme is the composite enzyme from step (1) and the lipase from step (2) immobilized on silica gel.

[0016] Preferably, the reaction in step (2) is carried out at 30-45°C for 2-6 hours.

[0017] Preferably, the settling time in step (2) is 20-40 minutes.

[0018] Preferably, the distillation separation conditions in step (2) are: cooling water temperature 45-55℃, vacuum degree 0.3-0.5Pa, film scraping speed 90-110r / min, and feed flow rate 5-12kg / min.

[0019] The beneficial effects of this invention are as follows: By strictly controlling the enzyme composition and free fatty acids during the hydrolysis and esterification process, this invention enables the content of diglycerides in the final product to reach more than 80%. Moreover, the reaction process is carried out in the order of hydrolysis and esterification, the process steps are simple, and no organic solvents are used in the entire reaction process, thus achieving green and environmentally friendly results. Attached Figure Description

[0020] Figure 1 Results of serum uric acid (UA) levels in each group of mice; Figure 2 Results of xanthine oxidase (XOD) activity assay in the serum of mice in each group; Figure 3 Results of serum creatinine (Cr) levels in each group of mice. Detailed Implementation

[0021] To clarify the purpose, technical solution, and advantages of this invention, the following detailed description is provided in conjunction with specific embodiments. To facilitate understanding of the technical means, creative features, and achieved objectives and effects of this invention, the following detailed description further clarifies the invention in conjunction with specific embodiments. However, these embodiments are merely preferred embodiments and not exhaustive. Other embodiments obtained by those skilled in the art based on the embodiments described herein without creative effort are all within the scope of protection of this invention. In the following embodiments, unless otherwise specified, the operating methods used are conventional operating methods, the equipment used is conventional equipment, and the equipment materials used in each embodiment are the same. This invention does not limit the source of the raw materials used. Unless otherwise specified, the raw materials used in this invention are all commercially available products in this technical field, with a purity of 98% or higher.

[0022] The keratinase described in the following examples or comparative examples was purchased from Beijing Innocare Technology Co., Ltd., catalog number Novozymes 51032; the lipase was purchased from Sigma-Aldrich, catalog number SAE0065.

[0023] Example 1: A method for preparing diglycerides with uric acid-lowering effects, the preparation method comprising the following steps: (1) 100g of low erucic acid rapeseed oil, 50mL of water, and 1g of silica gel immobilized complex enzyme (0.25g of lipase and 0.75g of keratinase) were partially hydrolyzed at 30℃ for 3.6h. At this time, the free fatty acid content in the system was 41.2wt%. After dehydration, the hydrolysate was obtained. (2) Add 2.5 times the amount of glycerol and 0.3% the amount of lipase to the hydrolysate obtained in step (1) and react at 40°C for 4 hours. Add water to remove excess glycerol, let stand for 30 minutes to separate the layers, collect the upper layer, inject the upper layer into a molecular distillation apparatus, control the cooling water temperature at 50°C, the vacuum degree at 0.4 Pa, the scraping speed at 100 r / min, and the feed flow rate at 10 kg / min, and perform distillation separation, decolorization and deodorization to obtain diglycerides.

[0024] Example 2: A method for preparing diglycerides with uric acid-lowering effects, the preparation method comprising the following steps: (1) 100g of low erucic acid rapeseed oil, 35mL of water, and 1.2g of silica gel immobilized complex enzyme (including 0.4g of lipase and 0.8g of keratinase) were partially hydrolyzed at 20℃ for 5h. At this time, the free fatty acid content in the system was 38.4wt%. After dehydration, the hydrolysate was obtained. (2) Add 2 times the amount of glycerol and 0.1% of the amount of lipase to the hydrolysate obtained in step (1) and react at 45°C for 6 hours. Add water to remove excess glycerol, let stand for 40 minutes to separate the layers, collect the upper layer, inject the upper layer into a molecular distillation apparatus, control the cooling water temperature at 45°C, the vacuum degree at 0.3 Pa, the scraping speed at 90 r / min, and the feed flow rate at 6 kg / min, and perform distillation separation, decolorization and deodorization to obtain diglycerides.

[0025] Example 3 A method for preparing diglycerides with uric acid-lowering effects, the preparation method comprising the following steps: (1) 100g of low erucic acid rapeseed oil, 40mL of water, and 0.6g of silica gel immobilized complex enzyme (including 0.1g of lipase and 0.5g of keratinase) were partially hydrolyzed at 40℃ for 2h. At this time, the free fatty acid content in the system was 45.6wt%. After dehydration, the hydrolysate was obtained. (2) Add 3 times the amount of glycerol and 0.5% the amount of lipase to the hydrolysate obtained in step (1) and react at 30°C for 6 hours. Add water to remove excess glycerol, let stand for 45 minutes to separate the layers, collect the upper layer, inject the upper layer into a molecular distillation apparatus, control the cooling water temperature at 55°C, the vacuum degree at 0.5 Pa, the scraping speed at 110 r / min, and the feed flow rate at 12 kg / min, and perform distillation separation, decolorization and deodorization to obtain diglycerides.

[0026] Comparative Example 1: The only difference from Example 1 is that in step (1), a composite enzyme is not used; only 1g of silica gel immobilized lipase is added, and the free fatty acid content in the system is measured to be 51.7%. The rest is the same as in Example 1.

[0027] Comparative Example 2: The only difference from Example 1 is that in step (1), a compound enzyme is not used; only 1g of silica gel immobilized keratinase is added, and the free fatty acid content in the system is measured to be 26.4%. The rest is the same as in Example 1.

[0028] Comparative Example 3: The only difference from Example 1 is the amount of complex enzyme added in step (1). In this comparative example, the amount of complex enzyme added was 2g, and the free fatty acid content in the system was measured to be 58.6%. The rest is the same as in Example 1.

[0029] Comparative Example 4: The only difference from Example 1 is the amount of compound enzyme added in step (1). In this comparative example, the amount of compound enzyme added is 0.3g, and the free fatty acid content in the system is measured to be 31.4%. The rest is the same as in Example 1.

[0030] Comparative Example 5: The only difference from Example 1 is the amount of lipase added in step (2). In this comparative example, the amount of lipase added is 0.05% of the amount of hydrolysis product. The rest is the same as in Example 1.

[0031] Comparative Example 6: The only difference from Example 1 is the amount of lipase added in step (2). In this comparative example, the amount of lipase added is 0.8% of the amount of hydrolysis product. The rest is the same as in Example 1.

[0032] Experimental Example 1: According to the method described in the literature "Liquid Chromatographic Analysis of Glycerides [J]" (Zhong Nanjing, Li Lin, Li Bing, etc. Modern Food Science and Technology, 2012, 28 (01): 123-126. DOI: 10.13982 / j.mfst.1673-9078.2012.01.008), the content of diglycerides in the products obtained in Examples 1-3 and Comparative Examples 1-6 was determined by HPLC-ELSD method. Each of the above examples and comparative examples was repeated 3 times, and the measurement results are shown in Table 1.

[0033] Table 1: Content of diglycerides in examples and comparative examples (mean ± SD, n = 3)

[0034] Experimental Example 2: Hypouricemic effect test 1. Experimental procedure In this study, an acute hyperuricemic mouse model was established by combining potassium oxonate (PO, 300 mg / kg) and hypoxanthine (HX, 500 mg / kg). Male SPF-grade Kunming mice were purchased from Hunan Slack Jingda Experimental Animal Co., Ltd., production license number: SCXK (Xiang) 2019-0004, and the body weight of the mice was 18-22 g. After one week of adaptive feeding, they were randomly divided into a normal control group, a model control group, a positive control group (allopurinol 5 mg / kg), Example 1-Example 3 groups, and Comparative Example 1-Comparative Example 6 groups (the dose was 0.6 g / kg for all), with 10 mice in each group. The normal control group and the model control group were intragastrically administered an equal amount of 0.5% CMC-Na solution, and the other groups were intragastrically administered the corresponding dose of the positive drug or the prepared diglyceride. They were continuously intragastrically administered for 9 days, once a day, and the body weight of the mice was recorded every day. One day before modeling, the mice were fasted but given water for 12 h. On the 10th day, except for the normal control group, the other groups were intraperitoneally injected with PO (300 mg / kg) and intragastrically administered HX (500 mg / kg) to establish a hyperuricemic mouse model. The normal control group was intraperitoneally injected and intragastrically administered an equal amount of 0.5% CMC-Na solution. One hour after modeling, they continued to be intragastrically administered the corresponding drug. One hour after drug administration, blood was taken to prepare serum, and the levels of XOD (xanthine oxidase), UA (uric acid), and Cr (serum creatinine) in the serum were measured using a standard kit. After blood collection, the mice were sacrificed, the liver and kidneys were removed and weighed, and the organ index was calculated. The calculation formula for the organ index is: organ index = organ mass / body weight, where the unit of the organ index is mg / g, the unit of the organ mass is mg, and the unit of the body weight is g.

[0035] 2. Data processing Data were statistically analyzed using IBM SPSS Statistics 23.0 software. Results are expressed as mean ± standard deviation. If the population follows a normal distribution, one-way analysis of variance (one-way ANOVA) was used. If the population does not follow a normal distribution, nonparametric tests were used. Pairwise comparisons between groups were performed using the Kruskal-Wallis test, with P < 0.05 considered statistically significant.

[0036] 3. Experimental Results 1) Effects on body weight The body weight measurements of mice in each group during the experiment are shown in Table 2.

[0037] Table 2: Body weight measurements of mice in each group during the experiment

[0038] According to the results in Table 2, there was no significant difference in body weight among the groups of mice during the drug administration period (P>0.05). On day 10, the body weight of mice in each group decreased significantly, which was related to fasting the night before modeling.

[0039] 2) Effects on organ indices The results of organ indices for each group of mice are shown in Table 3.

[0040] Table 3: Results of organ index in mice in each group

[0041] According to the results in Table 3, there were no significant differences in liver and kidney indices among the mice in each group during the drug administration period (P>0.05).

[0042] Based on the results of body weight and organ index, it can be seen that there were no obvious toxic side effects in mice in each treatment group.

[0043] 3) Effects on UA, XOD, and Cr See results Figures 1-3 In each figure, compared with the normal control group, % P<0.05, %% P<0.01; compared with the model control group, there were no significant differences between the drug administration groups. # P<0.05, ## P<0.01, ### P<0.001; compared with the group in Example 1, there were no significant differences between the drug administration groups. & P<0.05, && P<0.01.

[0044] Depend on Figure 1It was found that, compared with the normal control group, the serum UA in the model control group was significantly increased (P<0.01), indicating that the last intraperitoneal injection of PO combined with HX gavage could successfully establish an acute hyperuricemia mouse model. Compared with the model control group, all drug administration groups could reduce the serum UA value of model mice (P<0.05 or P<0.001), but the effect of the example was better than that of the comparative examples (P<0.05).

[0045] Depend on Figure 2 The results showed that, compared with the normal control group, the serum XOD activity in the model control group was significantly increased (P<0.01). XOD, as a key enzyme in the uric acid production process, further demonstrates that the last intraperitoneal injection of PO combined with HX gavage can successfully establish an acute hyperuricemia mouse model. Compared with the model control group, all treatment groups reduced the serum XOD activity in the model mice (P<0.05 or P<0.01), but the effect of the example was superior to that of the comparative groups (P<0.05 or P<0.01).

[0046] Depend on Figure 3 The results showed that, compared with the normal control group, the serum Cr level in the model control group was significantly increased (P<0.05), indicating that the hyperuricemia model causes a certain degree of kidney damage in mice. Compared with the model control group, all drug-treated groups reduced the serum Cr level in model mice (P<0.05), showing that each drug-treated group had a mitigating effect on kidney damage caused by hyperuricemia, but the effect of the example was better than that of comparative examples 1-5 (P<0.05).

[0047] In summary, the diglyceride product prepared by the method provided by this invention has a diglyceride content of over 80%, and can significantly reduce the activity or level of UA, XOD, and Cr in the serum of hyperuricemic model mice, with better effects than the comparative proportions.

[0048] Finally, it should be noted that the above content is only used to illustrate the technical solution of the present invention, and is not intended to limit the scope of protection of the present invention. Simple modifications or equivalent substitutions made by those skilled in the art to the technical solution of the present invention do not depart from the essence and scope of the technical solution of the present invention.

Claims

1. A method for preparing diglycerides with uric acid-lowering effects, characterized in that, The preparation method includes the following steps: (1) The vegetable oil is partially hydrolyzed by a complex enzyme catalytic hydrolysis method composed of lipase and keratinase, and the hydrolysate is obtained after dehydration. The free fatty acid content in the hydrolysate is between 37.0 wt% and 46.0 wt%. (2) After adding glycerol and lipase to the hydrolysate obtained in step (1), water is added to remove excess glycerol, the mixture is allowed to stand and separate into layers, the upper layer is collected, and the mixture is separated by distillation to obtain the edible diglyceride.

2. The preparation method according to claim 1, characterized in that, In step (1), the mass ratio of keratinase to lipase in the complex enzyme is 1:2-5.

3. The preparation method according to claim 1, characterized in that, The amount of the compound enzyme added in step (1) is 0.5%-1.2% of the mass of the edible oil.

4. The preparation method according to claim 1, characterized in that, In step (1), the oil-to-water ratio during hydrolysis is 2-3:1 g / mL, the reaction temperature is 20-40℃, and the reaction time is 2-5 h.

5. The preparation method according to claim 1, characterized in that, The vegetable oil mentioned in step (1) is selected from at least one of the following: Acer truncatum seed oil, Hippophae rhamnoides seed oil, low erucic acid rapeseed oil, peony seed oil, corn oil, peanut oil, flaxseed oil, safflower seed oil, and milk thistle seed oil.

6. The preparation method according to claim 1, characterized in that, The amount of glycerol added in step (2) is 2-3 times the mass of the hydrolysate in step (1), and the amount of lipase added is 0.1%-0.5% of the mass of the hydrolysate in step (1).

7. The preparation method according to claim 1, characterized in that, The enzymes used in steps (1) and (2) are immobilized enzymes, which are recovered after the catalytic reaction is completed.

8. The preparation method according to claim 1, characterized in that, The reaction described in step (2) is carried out at 30-45℃ for 2-6 hours.

9. The preparation method according to claim 1, characterized in that, The settling time in step (2) is 20-40 minutes.

10. The preparation method according to claim 1, characterized in that, The conditions for distillation separation in step (2) are: cooling water temperature 45-55℃, vacuum degree 0.3-0.5Pa, film scraping speed 90-110r / min, and feed flow rate 5-12kg / min.

Citation Information

Patent Citations

  • Method for preparing diglyceride through enzyme catalysis

    CN105400837A

  • Method for preparing diglyceride for reducing uric acid through enzymolysis as well as product and application of diglyceride

    CN119932125A